Selected Grants
PKP2 Dose Escalation Trial of RP-A601
Clinical TrialPrincipal Investigator · Awarded by Rocket Pharmaceuticals, Ltd · 2024 - 2029The Natural History of Arrhythmogenic Cardiomyopathy with Pathogenic PKP2 Variants (PKP2-ACM): An observational cohort study
Clinical TrialPrincipal Investigator · Awarded by Rocket Pharmaceuticals, Ltd · 2025 - 2029A Phase 2 Double-Blind, Repeat-Dose, Placebo-Controlled Crossover Study To Evaluate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia
Clinical TrialPrincipal Investigator · Awarded by Cardurion Pharmaceuticals, Inc. · 2025 - 2027AdaptResponse
Clinical TrialPrincipal Investigator · Awarded by Medtronic, Inc. · 2015 - 2022Inova Duke Cardiac Sudden Death in Young Athletes Symposium
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Inova Health System · 2020 - 2021Optimal Pacing in Patients with First-Degree AV-block
ResearchPrincipal Investigator · Awarded by Medtronic, Inc. · 2014 - 2018BD Star (Daubert)
ResearchPrincipal Investigator · Awarded by Boston Scientific Corporation · 2015 - 2016DUCCS Champion 415988-G (Late Sodium Current Blockage in High Risk ICD Patients)
ResearchPrincipal Investigator · Awarded by University of Rochester · 2011 - 2016External Relationships
- Affera, a Medtronic Company
- American Board of Internal Medicine
- Biosense Webster (Johnson & Johnson)
- Biotronik
- Boston Scientific Corporation
- Cordis Corporation
- McGraw-Hill Publishing
- Medtronic Inc.
- NIH/NHLBI
- Springboard Healthcare
- Synaptic Medical
- University of Rochester School of Medicine
- Wiley Publishing, Inc.
- Wolters Kluwer
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.